Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma

BACKGROUND & AIMS: This study is designed to analyze survival benefit of (neo-) adjuvant radiotherapy to patients with T2-3N0M0 stage esophageal adenocarcinoma (EAC). METHODS: T2-3N0M0 stage EAC patients from 2004 to 2012 were searched from the Surveillance Epidemiology and End Results (SEER) da...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yaqi, Tao, Guangzhou, Guo, Qing, Yang, Xi, Zhu, Hongcheng, Wang, Wanwei, Sun, Xinchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008289/
https://www.ncbi.nlm.nih.gov/pubmed/26870996
http://dx.doi.org/10.18632/oncotarget.7256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008289/
https://www.ncbi.nlm.nih.gov/pubmed/26870996
http://dx.doi.org/10.18632/oncotarget.7256

Ejemplares similares